cro.directory
← Compare landing

Charles River Laboratories vs Nuvisan

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/nuvisan

CategoryCharles River LaboratoriesNuvisan
Listed sitebothboth
SummaryCharles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.
Services
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Bioinformatics & Data Science
  • Genomics & Sequencing Services
  • Oncology Specialty Services
  • Translational Research
  • ICH Stability Studies
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Clinical Operations
  • Phase II Clinical Trials
  • Phase I Clinical Trials
  • Clinical Trial Services
  • Biomarker Assays
  • Bioanalysis
  • In Vivo PK / PD Studies
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Medicinal Chemistry
  • High-Throughput Screening
  • Discovery Research
  • Target Identification & Validation
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Formulation Development
  • Process Development
  • Technology Transfer
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Small Molecule
  • Biologics (Other)
Indications
  • Oncology
  • Immunology
  • Neurology
  • Oncology
  • Dermatology
Locations
  • Headquarters, United States
  • North America, North America, USA/Canada
  • Europe, Europe, Multiple
  • Asia, Asia, Multiple
  • North America, North America
  • Europe, Europe
  • Asia, Asia
  • Headquarters & Drug Discovery, Neu-Ulm, Baden-Württemberg, Germany
  • Bioanalytical Services, Neu-Ulm, Baden-Württemberg, Germany
  • Headquarters & Bioanalytical Services, Neu-Ulm, Baden-Württemberg, Germany
  • Headquarters, Neu-Ulm, Baden-Württemberg, Germany
  • Drug Discovery Research, Berlin, Berlin, Germany
  • Formulation Development & GMP Manufacturing, Sophia Antipolis, Provence-Alpes-Côte d'Azur, France
  • Drug Discovery, Berlin, Berlin, Germany
  • Formulation & GMP Manufacturing, Sophia Antipolis, Provence-Alpes-Côte d'Azur, France
Certifications
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.